ArticleJournal of neurology2025

Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.

Guillaume Mathey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.